|
AES expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.558100E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.105900E-02 |
| Normal-vs-Stage2 |
7.819600E-02 |
| Normal-vs-Stage3 |
4.206800E-01 |
| Normal-vs-Stage4 |
5.976200E-01 |
| Stage1-vs-Stage2 |
6.748800E-01 |
| Stage1-vs-Stage3 |
3.328800E-01 |
| Stage1-vs-Stage4 |
2.795400E-01 |
| Stage2-vs-Stage3 |
3.394000E-01 |
| Stage2-vs-Stage4 |
2.695600E-01 |
| Stage3-vs-Stage4 |
8.665600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.258600E-01 |
| Normal-vs-AfricanAmerican |
3.004000E-02 |
| Normal-vs-Asian |
4.514000E-02 |
| Caucasian-vs-AfricanAmerican |
1.133430E-01 |
| Caucasian-vs-Asian |
1.173450E-01 |
| AfricanAmerican-vs-Asian |
7.626800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.136170E-02 |
| Normal-vs-Female |
1.019370E-01 |
| Male-vs-Female |
1.592580E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.656100E-02 |
| Normal-vs-Age(41-60Yrs) |
5.413800E-02 |
| Normal-vs-Age(61-80Yrs) |
3.453600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.317200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.637600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.312600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.923400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.239200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.577000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.584200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.62489999999882E-05 |
| Classical-VS-Follicular |
3.842000E-02 |
| Classical-VS-Other |
1.962430E-01 |
| Classical-VS-Normal |
5.912300E-02 |
| Tall-VS-Follicular |
4.12180000020079E-07 |
| Tall-VS-Other |
2.520300E-02 |
| Tall-VS-Normal |
7.738000E-03 |
| Follicular-VS-Other |
5.687400E-01 |
| Follicular-VS-Normal |
1.478860E-03 |
| Other-VS-Normal |
1.215010E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.316560E-03 |
| Normal-vs-N1 |
2.135000E-01 |
| N0-vs-N1 |
3.010800E-01 |
|
|
